Clicking vaccine will link to illness discussion

Vaccines¹ are listed under the routinely recommended ages. Bars indicate the range of acceptable ages for immunization. Catch-up immunization should be done during any visit when feasible. Gray ovals indicate the vaccines to be assessed and given if necessary during the early adolescent visit.

Footnotes to the Table
On October 22, 1999, the ACIP recommended that Rotashield (RRV-TV), the only US-licensed rotavirus vaccine, no longer be used in the United States (MMWR.1999:48[43}:1007). Parents should be reassured that their children who received rotavirus vaccine before July are not at increased risk for intussusception now.
¹ This schedule indicates the recommended ages for routine administration of currently licensed childhood vaccines as of 11/1/99. Additional vaccines may be licensed and recommended during the year. Licensed combination vaccines may be used whenever any components of the combination are indicated and its other components are not contraindicated. Providers should consult the manufacturers' package inserts for detailed recommendations.
² INFANTS BORN TO HBsAg-NEGATIVE MOTHERS should receive the first dose of hepatitis B (Hep B) vaccine by age 2 months. The second dose should be at least 1 month after the first dose. The third dose should be administered at least 4 months after the first dose and at least 2 months after the second dose, but not before 6 months of age for infants.
   INFANTS BORN TO HBsAg-POSITIVE MOTHERS should receive hepatitis B vaccine and 0.5 mL hepatitis B immune globulin (HBIG) within 12 hours of birth at separate sites. The second dose is recommended at 1 month of age and the third dose at 6 months of age.
   INFANTS BORN TO MOTHERS WHOSE HBsAg STATUS IS UNKNOWN should receive hepatitis B vaccine within 12 hours of birth. Maternal blood should be drawn at the time of delivery to determine the mother's HBsAg status; if the HBsAg test is positive, the infant should receive HBIG as soon as possible (no later than 1 week of age).
   ALL CHILDREN AND ADOLESCENTS (THROUGH 18 YEARS OF AGE) who have not been immunized against hepatitis B may begin the series during any visit. Special efforts should be made to immunize children who were born in or whose parents were born in areas of the world with moderate or high endemicity of hepatitis B virus infection.
³ The fourth dose of DTaP (diphtheria and tetanus toxoids and acellular pertussis vaccine) may be administered as early as 12 months of age, provided 6 months have elapsed since the third dose and the child is unlikely to return at 15 to 18 months of age. Td (tetanus and diphtheria toxoids) is recommended at 11 to 12 years of age if at least 5 years have elapsed since the last dose of DTP, DTaP, or DT. Subsequent routine Td boosters are recommended every 10 years.
⁴ Three Haemophilus influenzae type b (Hib) conjugate vaccines are licensed for infant use. If PRP-OMP (PedvaxHIB or ComVax [Merck]) is administered at 2 and 4 months of age, a dose at 6 months is not required. Because clinical studies in infants have demonstrated that using some combination products may induce a lower immune response to the Hib vaccine component, DTaP/Hib combination products should not be used for primary immunization in infants at 2, 4, or 6 months of age, unless approved by the FDA for these ages.
⁵ To eliminate the risk of vaccine-associated paralytic polio (VAPP), an all-IPV schedule is now recommended for routine childhood polio vaccination in the United States. All children should receive four doses of IPV at 2 months, 4 months, 6 to 18 months, and 4 to 6 years. OPV (ifavailable) may be used only for the following special circumstances:
   Mass vaccination campaigns to control outbreaks of paralytic polio.
   Unvaccinated children who will be traveling in <4 weeks to areas where polio is endemic or epidemic.
   Children of parents who do not accept the recommended number of vaccine injections. These children may receive OPV
     only for  the third or fourth dose or both; in this situation, health care providers should administer OPV only after discussing
     the risk for VAPP with parents or caregivers.
   During the transition to an all-IPV schedule, recommendations for the use of remaining OPV supplies in physicians' offices 
     and clinics have been issued by the American Academy of Pediatrics (see Pediatrics. 1999; 104:1404-1406).
⁶ The second dose of measles, mumps, and rubella (MMR) vaccine is recommended routinely at 4 to 6 years of age but may be administered during any visit, provided at least 4 weeks have elapsed since receipt of the first dose and that both doses are administered beginning at or after 12 months of age. Those who have not previously received the second dose should complete the schedule by the 11-to-12-year-old visit.
⁷ Varicella (Var) vaccine is recommended at any visit on or after the first birthday for susceptible children,ie, those who lack a reliable history of chickenpox (as judged by a health care provided) and who have not been immunized. Susceptible persons 13 years of age or older should receive two doses, given at least 4 weeks apart.
⁸ Hepatitis A (Hep A) is shaded to indicate its recommended use in selected states and/or regions; consult your local public health authority. (Also see MMWR. 1999;48[RR12]:1-37).

Back